Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 525

1.

The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD.

Obeidat M, Dvorkin-Gheva A, Li X, Bossé Y, Brandsma CA, Nickle DC, Hansbro PM, Faner R, Agusti A, Paré PD, Stampfli MR, Sin DD.

Sci Rep. 2018 Aug 8;8(1):11881. doi: 10.1038/s41598-018-30313-z.

2.

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.

Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A.

ERJ Open Res. 2018 Aug 3;4(3). pii: 00022-2018. doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.

3.

The dyspnoea-inactivity vicious circle in COPD: Development and external validation of a conceptual model.

Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, Donaire-Gonzalez D, Ferrer J, Rodríguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2018 Aug 2. pii: 1800079. doi: 10.1183/13993003.00079-2018. [Epub ahead of print]

PMID:
30072504
4.

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD.

López-Giraldo A, Cruz T, Molins L, Guirao Á, Saco A, Cuerpo S, Ramirez J, Agustí Á, Faner R.

BMC Pulm Med. 2018 Jul 31;18(1):123. doi: 10.1186/s12890-018-0688-3.

5.

Whole exome sequencing analysis in severe chronic obstructive pulmonary disease.

Qiao D, Ameli A, Prokopenko D, Chen H, Kho AT, Parker MM, Morrow J, Hobbs BD, Liu Y, Beaty TH, Crapo JD, Barnes KC, Nickerson DA, Bamshad M, Hersh CP, Lomas DA, Agusti A, Make BJ, Calverley PMA, Donner CF, Wouters EF, Vestbo J, Paré PD, Levy RD, Rennard SI, Tal-Singer R, Spitz MR, Sharma A, Ruczinski I, Lange C, Silverman EK, Cho MH; NHLBI Exome Sequencing Project, University of Washington Center for Mendelian Genomics, Lung GO, COPDGene Investigators.

Hum Mol Genet. 2018 Jul 27. doi: 10.1093/hmg/ddy269. [Epub ahead of print]

PMID:
30060175
6.

Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.

Faner R, Noell G, Badia JR, López-Giraldo A, Bakke P, Silverman EK, Tal-Singer R, Agustí A.

Respir Med. 2018 Aug;141:14-19. doi: 10.1016/j.rmed.2018.06.015. Epub 2018 Jun 19.

PMID:
30053959
7.

Precision medicine in COPD exacerbations.

Agusti A, Faner R, Celli B, Rodriguez-Roisin R.

Lancet Respir Med. 2018 Jul 17. pii: S2213-2600(18)30296-0. doi: 10.1016/S2213-2600(18)30296-0. [Epub ahead of print] No abstract available.

PMID:
30029970
8.

How to Define Early COPD.

Agusti A, Faner R.

Am J Respir Crit Care Med. 2018 Jul 18. doi: 10.1164/rccm.201805-0880LE. [Epub ahead of print] No abstract available.

PMID:
30020809
9.

Bone marrow characterization in COPD: a multi-level network analysis.

Toledo-Pons N, Noell G, Jahn A, Iglesias A, Duran MA, Iglesias J, Rios A, Scrimini S, Faner R, Gigirey O, Agustí A, Cosío BG.

Respir Res. 2018 Jun 15;19(1):118. doi: 10.1186/s12931-018-0824-x.

10.

Pulmonary Vascular Involvement in COPD - Is There a Pulmonary Vascular Phenotype?

Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H.

Am J Respir Crit Care Med. 2018 May 10. doi: 10.1164/rccm.201801-0095PP. [Epub ahead of print]

PMID:
29746142
11.

Correction to: Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.

Olloquequi J, Jaime S, Parra V, Cornejo-Córdova E, Valdivia G, Agustí À, Silva RO.

Respir Res. 2018 Apr 30;19(1):77. doi: 10.1186/s12931-018-0765-4.

12.

COPD: time to improve its taxonomy?

Celli BR, Agustí A.

ERJ Open Res. 2018 Feb 16;4(1). pii: 00132-2017. doi: 10.1183/23120541.00132-2017. eCollection 2018 Jan.

13.

The Changing Landscape of COPD.

Agusti A, Faner R.

Am J Respir Crit Care Med. 2018 Apr 27. doi: 10.1164/rccm.201804-0714ED. [Epub ahead of print] No abstract available.

PMID:
29701997
14.

Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease.

Rodríguez-Roisin R, Krowka MJ, Agustí A.

Compr Physiol. 2018 Mar 25;8(2):711-729. doi: 10.1002/cphy.c170020.

PMID:
29687908
15.

Pharmacological treatment of COPD: the devil is always in the detail.

Singh D, Barnes PJ, Stockley R, Lopez Valera MV, Vogelmeier C, Agusti A.

Eur Respir J. 2018 Apr 19;51(4). pii: 1800263. doi: 10.1183/13993003.00263-2018. Print 2018 Apr. No abstract available.

PMID:
29674480
16.

The disease model: implications for clinical practice.

Agusti A.

Eur Respir J. 2018 Apr 12;51(4). pii: 1800188. doi: 10.1183/13993003.00188-2018. Print 2018 Apr. No abstract available.

PMID:
29650549
17.

Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function.

Agustí A, García-Pardo MP, López-Almela I, Campillo I, Maes M, Romaní-Pérez M, Sanz Y.

Front Neurosci. 2018 Mar 16;12:155. doi: 10.3389/fnins.2018.00155. eCollection 2018. Review.

18.

COPD beyond smoking: new paradigm, novel opportunities.

Agustí A, Faner R.

Lancet Respir Med. 2018 May;6(5):324-326. doi: 10.1016/S2213-2600(18)30060-2. Epub 2018 Feb 26. No abstract available.

PMID:
29496484
19.

Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee.

Fuentes Camps I, Rodríguez A, Agustí A.

Br J Clin Pharmacol. 2018 Jun;84(6):1384-1388. doi: 10.1111/bcp.13555. Epub 2018 Mar 22.

PMID:
29446851
20.

Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.

Celli BR, Locantore N, Tal-Singer R, Riley J, Miller B, Vestbo J, Yates JC, Silverman EK, Owen CA, Divo M, Pinto-Plata V, Wouters EFM, Faner R, Agusti A; ECLIPSE Study Investigators.

Eur Respir J. 2018 Feb 7;51(2). pii: 1702146. doi: 10.1183/13993003.02146-2017. Print 2018 Feb.

PMID:
29437944

Supplemental Content

Loading ...
Support Center